Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

CLL Society’s Research Program General Eligibility Criteria

CLL Society is committed to embracing diversity and building spaces of equitable representation to meet the unmet needs of all individuals living with chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL / SLL) in every aspect of our programs and support services. We believe that in order to meet the needs of all CLL / SLL patients, we must be intentional about ensuring diverse representation in research. CLL Society embodies this belief by identifying and minimizing health disparities across racial and ethnic groups as a key objective of the Research Program.

We look forward to funding investigators who are inclusive of diversity in their research proposals and who are continually looking to establish a better understanding of the unmet needs of CLL / SLL patients across all demographic groups.

CLL Society believes minority applicants are valued members of the research community and are vital to its success. Women and underrepresented minorities are particularly encouraged to apply.

Eligible:

Please thoroughly read the RFP document for the grant you are applying for, as there is additional eligibility information that is specific to each individual grant. The RFP can be found on the Current Funding Opportunities page. General eligibility requirements that are specific to all CLL Society grants include:

  • The research must be conducted at a non-profit academic institution located within the United States.
  • Applicants must be directly associated with a sponsoring institution or fiscal agent to receive grant funding, as CLL Society funding must be paid directly to the academic institution and not the researcher. 
  • Adjustments for career interruptions can be made. These could include but are not limited to family leave, military service, major illness, or injury. It will be the responsibility of the awardee to document such interruptions and notify CLL Society’s Research Program Administrator as soon as possible should any interruptions occur.
  • The awardee must agree to acknowledge CLL Society in any publications or presentations that result from the funding.
  • The awardee must agree to provide annual Scientific Progress Reports and annual Financial Reports as will be outlined within the award agreement. this document will be provided to the academic institution for review and signatures after the awardee has been selected.
  • Previous recipients of CLL Society research funding are eligible to re-apply. However, awardees cannot have concurrent funding from CLL Society for more than one type of CLL Society grant at any given time.
  • Applicants are allowed to submit one application per award type per year. Should more than one proposal be selected by each Research Review Committee in any given year, only one award will be allowed for funding. The applicant will be asked to choose which grant type they would like to receive funding for at the prompting of the Research Review Committee.

Ineligible:

  • Research that would be performed outside of the United States.
  • Applicants should only submit one letter of intent per CLL Society award type in any given year. Submitting multiple letters of intent for the same type of award in any given year will result in automatic disqualification. Individuals will be allowed to submit one application per award type, but will only be awarded one. 
  • Industry-sponsored clinical trials are not allowed.

For additional questions regarding eligibility, please email [email protected].